final update goloran

Upload: fernan-globen-talonding

Post on 08-Feb-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/22/2019 Final Update Goloran

    1/54

    Pre-Operative

    Case

    PresentationUpdateGS II (DR. BRAVO/TEMONIO/DONAYRE/NOVENO)Department of Surgery

    Davao Regional Hospital, Tagum City

  • 7/22/2019 Final Update Goloran

    2/54

    General Data

    J. G.

    19 years old

    Male

    Single

    Filipino Roman Catholic

    Patin-ay, Prosperidad, Agusan del Sur

  • 7/22/2019 Final Update Goloran

    3/54

    Diagnostics

    Chest X-Ray PA Negative Chest

    Abdomen U/S

    Nothing significant in the abdomen

    Pelvis AP

    No significant abnormality is noted

  • 7/22/2019 Final Update Goloran

    4/54

  • 7/22/2019 Final Update Goloran

    5/54

    UPRIGHT VIEW VIEW

  • 7/22/2019 Final Update Goloran

    6/54

  • 7/22/2019 Final Update Goloran

    7/54

    R FEMUR

  • 7/22/2019 Final Update Goloran

    8/54

    INTERNAL MEDECINE RODs IMPRESSION:

    Anemia sec to UGIB (resolved) probably sec. to Liver

    Schistosomiasis;

    Palpable LLQ mass.

  • 7/22/2019 Final Update Goloran

    9/54

    Salient Points

    History

    (+) history of vehicular crash

    (+) mass LLQ area, enlarging,tender

    (+) icterisia

    (+) melena

    (+) fever

    (+) SCHISTOSOMIASIS 4 yrsPTA treatment given as

    claimed

    (+) Lives in an area infested to

    Schistosoma parasite

    Physical Examination

    Temperature: 37OC

    (+) jaundice Icteric sclera, pale palpebral

    conjunctiva

    Liver edge 5cms

    palpable mass at the LLQ

    (approximately 10cm X 4cm), non-tender, fixed, no skin discoloration

    above the mass

    (+) Deformity R thigh

  • 7/22/2019 Final Update Goloran

    10/54

    IMPRESSION

    1. ANEMIA SEC PROB SEC TO BPUD PROB SEC TOBLEEDING PEPTIC ULCER DISEASE

    2. OBSTRUCTIVE JAUNDICE SEC TO CHOLELITHIASIS ANDCHOLEDOCHOLITHIASIS NOT IN CHOLANGITIS

    3. PANCREATIC TAIL MASS, T/C PSEUDOCYST

    4. LEFT LOWER QUADRANT MASS PROBABLY COLONIC INORIGIN

    5. NEGLECTED CLOSED FEMORAL FRACTURE, M3RD,RIGHT SEC TO VA

  • 7/22/2019 Final Update Goloran

    11/54

    PREVIOUS

    PLANS

  • 7/22/2019 Final Update Goloran

    12/54

    PLAN A

    OPTIMIZED PATIENTS STATUS:

    NUTRITIONALLY,

    PHYSICALLY, PSYCHOLOGICALLY

  • 7/22/2019 Final Update Goloran

    13/54

    PLAN B

    Treatment of UGIB:

    For UGI Endoscopy

  • 7/22/2019 Final Update Goloran

    14/54

    PLAN C

    For Treatment of Obstuctive Jaundice sec to Choledocholithiais

    and Cholelithiasis:

    ERCP OPEN CHOLECYSTECTECTOMY WITH CBDE, IOC, TUBE

    CHOLEDOCHOSTOMY

  • 7/22/2019 Final Update Goloran

    15/54

    PLAN D

    IF (+) Pancreatic tail mass (PSEUDOCYST): CA19-9 DETERMINATION

    CT SCAN OF THE CHEST, ABDOMEN, PELVIS (TRIPLE CONTAST)

    DRAINAGE:

    (EXTERNAL) Percutaneous catheter drainage- high chance of persistent

    pancreatic fistula (ultrasound or CT scan guided)

    (INTERNAL) Endoscopic drainage- less invasive, becoming more popular,

    techically demanding

    Cyst gastrostomy

    Cyst doudenostomy

    Cyst jejnunostomy

    Segmental resection and Roux-n-Y reconstruction

    DISTAL PANCREACTECTOMY

    necessary in complicated pseudocysts, failed nonsurgical, and multiplepseudocysts

  • 7/22/2019 Final Update Goloran

    16/54

    PLAN E

    For the LLQ mass t/c Colonic in origin:

    Colonoscopy w/ biopsy

    CT SCAN OF THE CHEST, ABDOMEN, PELVIS

    (TRIPLE CONTAST)

    Baseline CEA

  • 7/22/2019 Final Update Goloran

    17/54

    PLAN F

    For treatment of Schistosomiasis:

    Stool examination Rectal biopsy - DONE

  • 7/22/2019 Final Update Goloran

    18/54

    PLAN F

    Treatment of Neglected Femoral Fracture:

    Refer to Ortho Consultant

    For ORIF, Intramedullary Nailing, Right Femur

  • 7/22/2019 Final Update Goloran

    19/54

    LATEST DIAGMOSITICS

  • 7/22/2019 Final Update Goloran

    20/54

    CT Scan of the whole abdomen

    done w/c revealed:

  • 7/22/2019 Final Update Goloran

    21/54

  • 7/22/2019 Final Update Goloran

    22/54

    IMPRESSIONS:

    INTRAHEPATIC AND EXTRAHEPATIC BILIARYDILATATION DUE TO AN OBSTRUCTING CALCULUSOR MASS IN THE PANCREATIC PORTION OF THE CBD.

    GALLBLADDER CALCULUS WITH INFLAMMATORY

    CHANGES IN THE GALLBLADDER WALL. CONSIDERALSO A ROUNDWORM (ASCARIS) OR ITS CARCASSWITHIN THE CBD AND GALLBLADDER

    HEPATOMEGALY AND SPLENOMEGALY

    ILIOPSOAS AND INGUINAL ABSCESS, LEFT

  • 7/22/2019 Final Update Goloran

    23/54

    Diagnostics

    CBC Nov. 14, 2013 Nov. 16, 2013 Normal Values

    Hemoglobin

    97(L) 90(L) 140170 g/LHematocrit

    0.29(L) 0.26(L) 0.400.50

    WBC

    16.4(H) 14.2(H) 5.010.0 X 109/L

    Neutrophils

    0.84(H) 0.84(H) 0.550.65%Lymphocytes

    0.11(L) 0.10(L) 0.250.35%

    Monocytes0.05 0.06(H) 0.020.05%

    Platelets

    660(H) 565(H) 150500 X 109/L

  • 7/22/2019 Final Update Goloran

    24/54

    Diagnostics

    Reticulocyte Count: 37 (H) 1.12.7%

    MCV: 77 (L) 8298fL

    MCH: 28.3 2833pg

    Amylase 48.80 28100U/L

  • 7/22/2019 Final Update Goloran

    25/54

    Diagnostics

    Prothrombin

    TimeNovember

    14, 2013

    Normal

    ValuesPT - %

    Activity 82%

    PTControl13.1 15.0sec

    PTINR 1.13

    PT - Patient

    14.4 1117sec

    Blood No ember 14 N b 16

  • 7/22/2019 Final Update Goloran

    26/54

    Diagnostics

    Blood

    Chemistry

    November 14,

    2013

    November 16,

    2013Normal Values

    Sodium137.10 141.30

    135

    148mmol/L

    Potassium4.40 4.10 3.55.5mmol/L

    Calcium 1.25 1.20 1.11.4mmol/L

    Chloride 111.90 105.20 97110mmol/L

    Creatinine53.50 60.50

    53

    115.0umol/LTotal Bilirubin

    ----- -----2.0

    21.0mmol/L

    Direct Bilirubin ----- ----- 0.13.4mmol/L

    Indirect

    Bilirubin ----- ----- 014.50mmol/L

    Alkaline

    Phosphatase----- ----- 35130U/L

    Albumin 21.97(L) ----- 3550g/L

    SGOT/AST ----- ----- 042U/L

    SGPT/ALT ----- ----- 041U/L

  • 7/22/2019 Final Update Goloran

    27/54

    Total

    Bilirubin329.05 (H) ----- -----

    2.0

    21.0mmol/L

    Direct

    Bilirubin 232.62 (H) ----- -----0.1

    3.4mmol/L

    Indirect

    Bilirubin96.43 (H) ----- -----

    0

    14.50mmol/L

    Alkaline

    Phosphatase672.20 (H) ----- ----- 35130U/L

    Albumin ----- ----- 3550g/L

    SGOT/AST 140.20 (H) ----- ----- 042U/L

    SGPT/ALT 76.6 (H) ----- ----- 041U/L

  • 7/22/2019 Final Update Goloran

    28/54

    Diagnostics

    Arterial

    Blood Gas October30, 2013October30, 2013

    November1, 2013

    NormalValues

    pH 7.122 (L) 7.359 7.403 7.357.45

    pCO2 25.0 (L) 22.3 (L) 26.5 (L) 3545

    HCO3 10.4 (L) 16.1 (L) 19.1 (L) 2226O2Sat 93.6% 93.6% 98.1% 80100

  • 7/22/2019 Final Update Goloran

    29/54

    LATEST ABG

  • 7/22/2019 Final Update Goloran

    30/54

    Diagnostics

    Stool Exam November 13,

    2013

    Normal

    Values

    Color Yellowish

    brown7.357.45

    Consistency Soft 3545

    Ova/ParasitesNone seen 80100

  • 7/22/2019 Final Update Goloran

    31/54

    Diagnostics

    Urinalysis November 11,

    2013

    Normal

    Values

    Color Yellowish

    brown-----

    TransparencySoft -----

    pH7.0 -----

    Specific

    Gravity1.015 -----

    AlbuminTrace -----

    Pus Cells02 -----

    RBC01 -----

    Epithelial

    Cells

    Occasional -----

  • 7/22/2019 Final Update Goloran

    32/54

    Peripheral blood smear:

  • 7/22/2019 Final Update Goloran

    33/54

    Rectal Biopsy done:

  • 7/22/2019 Final Update Goloran

    34/54

    CHILDS PUGHCLASSIFICTION

    Factor 1 point 2 points 3 points

    Total bilirubin

    (mol/L)

    50

    Serum albumin(g/L)

    >35 28-35

  • 7/22/2019 Final Update Goloran

    35/54

    CHILDS PUGHCLASSIFICTION

    Class A Class B Class C

    Total points 5-6 7-9 10-15

    1-year survival 100% 80% 45%2-year survival 85% 60% 35%

  • 7/22/2019 Final Update Goloran

    36/54

    FINAL DIAGNOSIS

    1. ILIOPSOAS AND INGUINAL ABSCESS, LEFT

    2. OBSTRUCTIVE JAUNDICE SEC TOCHOLEDOCHOLITHIASIS VS CARCASS, CHOLELITHIASIS,

    NOT IN CHOLANGITIS

    3. ANEMIA PROB SEC TO BLEEDING ESOPHAGEAL VARICES

    PROB SEC TO PORTAL HYPERTENSION PROB SEC TOLIVER SCHISTOSOMIASIS

    4. NEGLECTED CLOSED FEMORAL FRACTURE, M3RD,

    RIGHT SEC TO VA

  • 7/22/2019 Final Update Goloran

    37/54

    Functional Status

  • 7/22/2019 Final Update Goloran

    38/54

    PRESENT

    PLANS

  • 7/22/2019 Final Update Goloran

    39/54

    PLAN A

    1. OPTIMIZED PATIENTS STATUS:

    NUTRITIONALLY,

    PHYSICALLY,

    PSYCHOLOGICALLY,

    EMOTIONALLY

  • 7/22/2019 Final Update Goloran

    40/54

    PLAN B

    1. For Treatment of Iliopsoas and Inguinal Abscess,

    Left:

    PERCUTANEOUS DRAINAGE OF Iliopsoas and Inguinal

    Abscess, Left, JP DRAIN

    OR EXLAP, Evacuation of Iliopsoas and Inguinal Abscess,

    Drain

  • 7/22/2019 Final Update Goloran

    41/54

    PLAN C

    1. For Treatment of Obstructive Jaundice sec to

    Choledocholithiasis vs Carcass, Cholelithiasis, not in

    Cholangitis:

    OPEN CHOLECYSTECTECTOMY WITH CBDE, IOC, TUBE

    CHOLEDOCHOSTOMY

  • 7/22/2019 Final Update Goloran

    42/54

    PLAN D

    1. Anemia prob sec to Bleeding Esophageal Varices prob sec to

    portal hypertension sec to Liver Schistosomiasis:

    CORRECT ANEMIA WITH BLOOD TRASFUSION

    UGI ENDOSCOPY

    IF POSITIVE WITH BEV:

    SCLEROTHERAPHY OF THE ESOPHAGEAL VARICES

    HASSABSS PROCEDURE

    is a satisfactory approach to controlling varices

    Steps:

    1. Splenectomy

    2. Devascularization of the distal 7 cm of the esophagaus

    3. Devascularization of the proximal part of the stomach

    4. Vagotomyand pyeloroplasty

    http://en.wikipedia.org/wiki/Splenectomyhttp://en.wikipedia.org/wiki/Vagotomyhttp://en.wikipedia.org/wiki/Vagotomyhttp://en.wikipedia.org/wiki/Splenectomy
  • 7/22/2019 Final Update Goloran

    43/54

    TREATMENT OF SCHISTOSOMIASIS:

  • 7/22/2019 Final Update Goloran

    44/54

    PLAN E

    Treatment of Neglected Femoral Fracture:

    For ORIF, Intramedullary Nailing, Right Femur

  • 7/22/2019 Final Update Goloran

    45/54

    DISCUSSION

  • 7/22/2019 Final Update Goloran

    46/54

    Non-shunt procedures in

    management of variceal

    bleeding

  • 7/22/2019 Final Update Goloran

    47/54

    Most episodes of variceal haemorrhage will besuccessfully treated by resuscitation and injection

    sclerotherapy, and indeed the efficacy of this approachhas now been confirmed by several well-controlled trials.

    Nevertheless, in a significant minority either acutebleeding will persist, or rebleeding will occur in the nearor long term.

    In this situation there is little doubt that some form ofportal hypertension systemic decompression is the mostsuccessful treatment for bleeding.

  • 7/22/2019 Final Update Goloran

    48/54

    In the vast majority of centres, the currently favoured

    non-shunting procedures are:

    simple stapled esophageal transection,

    esophagogastric devascularization

    combination of the two

  • 7/22/2019 Final Update Goloran

    49/54

    Portoazygous

    Disconnection

  • 7/22/2019 Final Update Goloran

    50/54

    Hassab procedure

    Consists of devascularization of the upper half of the stomachand oesophagus

    The first step is usually splenic artery ligation followed bycareful mobilization of the spleen. This mobilization as in alldissections in portal hypertension, requires patient ligation andcoagulation of multiple collaterals within the peritonealreflections, and after individual ligation and division of theshort gastric vessels, the spleen is removed

    The whole proximal stomach is then devascularized from theterminal two branches of the left gastric artery at the incisura

    angularis upwards by ligation and division of the lesser andgreater omentum, and of the posterior gastric adhesions.

  • 7/22/2019 Final Update Goloran

    51/54

    Hassab procedure

    After division of the oesophagogastric reflection of peritoneum andmobilization of the vagi, the distal 7 to 8 cm of oesophagus is

    mobilized and all feeding vessels are ligated and divided. Exposurein this part of the procedure is much facilitated by the use of costalmargin retractors

    The distal 3 cm of oesophagus and proximal 5 cm of stomach maythen be opened longitudinally thus displaying the varices and

    allowing obliteration of each variceal column by undersewing fromas high as possible within the oesophagus with an absorbable suture

    After positioning of a nasogastric tube the oesophagogastrotomy iscarefully closed by suturing or stapling. Some authors recommend

    closure by swinging a flap of stomach wall into the oesophagealdefect, thus minimizing oesophageal stricturing.

  • 7/22/2019 Final Update Goloran

    52/54

    Sugiura procedure

    is a much more radical development of the above

    method, classically performed in two staged procedures

    At the first operation, via a left thoracotomy, the distal

    intrathoracic oesophagus is devascularized and an

    oesophageal transection performed. Six weeks later, via

    an upper abdominal midline incision, the intra-abdominal

    oesophagus and proximal stomach are devascularized by

    lesser and greater curve division and splenectomy

  • 7/22/2019 Final Update Goloran

    53/54

    Sugiura procedure

    Vagotomy and pyloroplasty are then performed.

    This massive procedure has been modified into a one-

    stage operation using a transabdominal approach

    facilitated by the use of costal margin and sternal

    retractors.

    After division of the crura of the diaphragm, 10 cm of

    oesophagus can be devascularized, a staple transection

    performed via a gastrotomy and the rest of the abdominal

    part of the operation completed.

  • 7/22/2019 Final Update Goloran

    54/54

    THANK YOU!!!!